Zeb2 drives the formation of CD11c + atypical B cells to sustain germinal centers that control persistent infection
Science Immunology · 29.03.2024 · 9 (93)
DOI: 10.1126/sciimmunol.adj4748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 29.03.2024. Verfasst von Xin Gao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia. Hauptthemen laut MEDLINE: Germinal Center, Persistent Infection. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
CD11c + atypical B cells (ABCs) are an alternative memory B cell lineage associated with immunization, infection, and autoimmunity. However, the factors that drive the transcriptional program of ABCs have not been identified, and the function of this population remains incompletely understood. Here, we identified candidate transcription factors associated with the ABC population based on a human tonsillar B cell single-cell dataset. We identified CD11c + B cells in mice with a similar transcriptomic signature to human ABCs, and using an optimized CRISPR-Cas9 knockdown screen, we observed that loss of zinc finger E-box binding homeobox 2 (Zeb2) impaired ABC formation. Furthermore, ZEB2 haplo-insufficient Mowat-Wilson syndrome (MWS) patients have decreased circulating ABCs in the blood. In Cd23 Cre/+ Zeb2 fl/fl mice with impaired ABC formation, ABCs were dispensable for efficient humoral responses after Plasmodium sporozoite immunization but were required to control recrudescent blood-stage malaria. Immune phenotyping revealed that ABCs drive optimal T follicular helper (T FH ) cell formation and germinal center (GC) responses and they reside at the red/white pulp border, likely permitting better access to pathogen antigens for presentation. Collectively, our study shows that ABC formation is dependent on Zeb2, and these cells can limit recrudescent infection by sustaining GC reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
- Francis Crick Institute, London, UK.
- Sydney Children's Hospital, Randwick, Australia.
- School of Women's and Children's Health, UNSW Sydney, Sydney, Australia.
- Kirby Institute, UNSW Sydney, Sydney, Australia.
- Australian Cancer Research Foundation Biomolecular Resource Facility, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
ORCID-Profile: Xin Gao, Katie Frith, C Mee Ling Munier, Fiona D Ballard, Hannah G Kelly, Jin-Shu He, Rebecca Jaeger, Patricia Carreira, Julia I Ellyard, Lynette Beattie, Anselm Enders, Matthew C Cook, John J Zaunders, Ian A Cockburn
Zitieren
APA
Gao, X., Shen, Q., Roco, J. A., Dalton, B., Frith, K., Munier, C. M. L., Ballard, F. D., Wang, K., Kelly, H. G., Nekrasov, M., He, J. S., Jaeger, R., Carreira, P., Ellyard, J. I., Beattie, L., Enders, A., Cook, M. C., Zaunders, J. J., & Cockburn, I. A. (2024). Zeb2 drives the formation of CD11c + atypical B cells to sustain germinal centers that control persistent infection. Science Immunology, 9(93). https://doi.org/10.1126/sciimmunol.adj4748
Vancouver
Gao X, Shen Q, Roco JA, Dalton B, Frith K, Munier CML, et al. Zeb2 drives the formation of CD11c + atypical B cells to sustain germinal centers that control persistent infection. Science Immunology. 2024;9(93). doi:10.1126/sciimmunol.adj4748
BibTeX
@article{Gao2024,
author = {Gao, Xin and Shen, Qian and Roco, Jonathan A and Dalton, Becan and Frith, Katie and Munier, C Mee Ling and Ballard, Fiona D and Wang, Ke and Kelly, Hannah G and Nekrasov, Maxim and He, Jin-Shu and Jaeger, Rebecca and Carreira, Patricia and Ellyard, Julia I and Beattie, Lynette and Enders, Anselm and Cook, Matthew C and Zaunders, John J and Cockburn, Ian A},
title = {Zeb2 drives the formation of CD11c + atypical B cells to sustain germinal centers that control persistent infection},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {93},
doi = {10.1126/sciimmunol.adj4748}
}
EUVIMED